Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Ex-Lax reformulation

This article was originally published in The Tan Sheet

Executive Summary

Ex-Lax reformulation: Novartis running informational, public service-type ads beginning in early October notifying consumers of the reformulation of the laxative product with senna. The product is being reformulated in response to FDA's Aug. 29 proposed rule banning the OTC sale of phenolphthalein ("The Tan Sheet" Sept. 1, p. 1). The ad, designed by New York City-based Grey Advertising, features a spokesperson discussing what consumers can expect, where they can obtain coupons and a 1-800 number to request information. No print ads will be run as part of the pre-launch campaign. A promotional campaign will begin closer to the launch date for the revamped product, which the company said would be on shelves by the beginning of November...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087552

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel